Ophthalmic phototherapy system and associated method
First Claim
Patent Images
1. A system for treating inflammatory eye disease inside an eye of a patient, comprising:
- an ophthalmic imaging device; and
an ophthalmic phototherapy device that includes;
a first light-emitting mechanism comprising an LED or a low-power laser source, that in operation emits a first light of at least a first wavelength in a near infra-red light wavelength range, a yellow light wavelength range, or a red light wavelength range;
a second light-emitting mechanism comprising an LED or a low-power laser source, that in operation emits a second light of at least a second wavelength different from the first wavelength; and
a controller comprising processing circuitry that in operation controls the first and second light-emitting mechanism so as to selectively direct the first and the second light from the ophthalmic phototherapy device into the eye of the patient being treated by the ophthalmic phototherapy device for first and second preselected periods of time, respectively.
0 Assignments
0 Petitions
Accused Products
Abstract
An ophthalmic phototherapy device and associated phototherapy treatment method tor promoting healing of damaged or diseased eye tissue. The ophthalmic phototherapy device includes a light emitting mechanism for transmitting light of at least one preselected wavelength to the eye tissue. The ophthalmic phototherapy method includes directing light of at least one wavelength for a selected period of time to a portion of damaged or diseased eye tissue, whereby the light transmitted to the damaged or diseased eye tissue stimulates cellular activity in the eye tissue to promote healing.
-
Citations
21 Claims
-
1. A system for treating inflammatory eye disease inside an eye of a patient, comprising:
-
an ophthalmic imaging device; and an ophthalmic phototherapy device that includes; a first light-emitting mechanism comprising an LED or a low-power laser source, that in operation emits a first light of at least a first wavelength in a near infra-red light wavelength range, a yellow light wavelength range, or a red light wavelength range; a second light-emitting mechanism comprising an LED or a low-power laser source, that in operation emits a second light of at least a second wavelength different from the first wavelength; and a controller comprising processing circuitry that in operation controls the first and second light-emitting mechanism so as to selectively direct the first and the second light from the ophthalmic phototherapy device into the eye of the patient being treated by the ophthalmic phototherapy device for first and second preselected periods of time, respectively. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A method for treating inflammatory eye disease inside an eye of a patient, the method comprising:
-
receiving an ophthalmic image of the eye of the patient that indicates the presence of inflammatory disease in the eye; providing an ophthalmic phototherapy device that includes (1) a first light-emitting device comprising an LED or a low power laser source, that in operation emits a first light of at least a first wavelength in a near infra-red light wavelength range, a yellow light wavelength range, or a red light wavelength range, (2) a second light-emitting device comprising an LED or a low power laser source, that in operation emits a second light of at least a second wavelength different from the first wavelength, and (3) a controller comprising processing circuitry that in operation controls the first and second light-emitting devices so as to selectively direct the first and second lights from the ophthalmic phototherapy device into the eye of the patient to be treated by the ophthalmic phototherapy device for first and second preselected periods of time, respectively; directing, for the first preselected period of time, the first light into the eye of the patient to expose at least a portion of an affected eye tissue inside the eye to the first light, wherein the first light has a first preselected brightness; and directing, for the second preselected period of time, the second light into the eye of the patient to expose the portion of the affected eye tissue to the second light, wherein the second light has a second preselected brightness, wherein the first wavelength of the first light is different from the second wavelength of the second light. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21)
-
Specification